Search
Research
Resourceful and creative methods are necessary to research rare disordersOur investigation used the infrastructure of InterRett, established in 2002 with dual aims of encour- aging international collaboration and ascertaining the...
Research
Group A streptococcal vaccines: Paving a path for accelerated developmentVaccine prevention of GAS infections and their immunological complications has been a goal of researchers for decades.
Research
Maternal Alcohol Use and Sudden Infant Death Syndrome and Infant Mortality Excluding SIDSThe highest risk of SIDS occurred when a maternal alcohol diagnosis was recorded during pregnancy or within 1 year postpregnancy.
Research
Associations between Handedness and Cerebral Lateralisation for Language: A Comparison of Three Measures in ChildrenIt has been suggested that quantitative measures of differential hand skill or reaching preference may provide more valid measures than traditional...
Research
The International Collaboration for Autism Registry Epidemiology (iCARE): Multinational Registry-Based Investigations of Autism Risk Factors and TrendsiCARE provides a unique, unprecedented resource in autism research that will significantly enhance the ability to detect environmental and genetic...
Research
Early Onset Binge Eating and Purging Eating Disorders: Course and Outcome in a Population-Based Study of AdolescentsPurging at age 17 and externalising behaviour problems at age 14 were the strongest predictors of eating disorder persistence to age 20.
Researchers from The Kids Research Institute Australia would like to understand more about respiratory syncytial virus (RSV) and how we can provide the best protection for kids.
Vaccine Trials Group with Sir Charles Gairdner Hospital is conducting a trial of a vaccine against Clostridium difficile infection (CDI) in at-risk individuals.
Researchers at The Kids Research Institute Australia are studying a new pneumococcal vaccine designed to provide a broader protection for 21 serotypes of the bacteria S. pneumoniae – 8 more serotypes than the current vaccine given to new babies.
Highlights from the VTG Laboratory in 2024